|
|
Mr. Meyers has over 18 years of experience representing pharmaceutical and biotechnology companies. He advises companies and investors on creating and implementing patent strategies to promote commercial and business goals.
Mr. Meyers represents public and private companies, investors, and academic institutions in the life sciences arena. His portfolio of life science companies spans diagnostics, life science tools and technology platforms, genomics and genetics and therapeutics. He also advises companies in these sectors: medical devices (cardiology, orthopedics, neurology, spine), organic and medicinal chemistry (including synthetic processes, industrial processes, small molecule synthesis, labeling dyes), and optics (fluorescent detection; microscopy).
As part of Brown Rudnick’s Cleantech Team, Mr. Meyers is also part of collaborative, cross-disciplinary initiatives to assist clients in this evolving sector.
Before joining Brown Rudnick, Mr. Meyers was a partner at Testa Hurwitz & Thibeault LLP and later Chair of the Intellectual Property Department at Sullivan & Worcester LLP. From 2004 – 2007, Mr. Meyers served as Vice President and General Counsel of Helicos BioSciences Corporation, where he directed and implemented patent and legal strategies and played a significant role in that company’s successful IPO.
Mr. Meyers speaks and writes extensively on strategic planning, partnering and patent matters, and presents frequently at major pharma and life sciences meetings. In addition, he advises pharmaceutical company analysts and serves as a resource for the press on matters relating to pharmaceutical litigation. Mr. Meyers is also an adjunct professor of law at Suffolk University Law School.
Representative Matters
• Developed and implemented patent strategy for numerous companies, resulting in successful IPOs, acquisitions, sales and enforcement.
• Represents venture capitalists in IP diligence matters.
• Negotiated and drafted numerous partnering deals, including a diagnostics company in $150+ million license deal.
• Represented tools company in $10 million licensing transaction.
• Handled a significant number of corporate and academic in-licensing and out-licensing deals.
• Represents clients in patent interference and reexamination proceedings.
Publications
• “Intellectual Property Strategic Planning for Biotechnology Startups,” J. Biolaw & Business, Vol. 4 (2001)
• “Patenting and Financing Bioinformatic Inventions,” Boston University Journal of Science Technology, Vol. 8 (2002)
• “Patent Protection of Protein Structures and Databases,” Nature Structural Biology, Vol. 7 (2000)
• “Field of Use Restrictions as Procompetitive Elements in Patent and Know-How License Agreements in the US and Europe,” Northwestern Journal of International. Law & Business, Vol. 12 (1991), cited as one of the year’s best intellectual property articles and reprinted in Intellectual Property Law Review, Vol. 25 (1993)
Speaking Engagements
• Panelist, "The Past, Present and Future of Gene Patenting," New York Biotechnology Association Annual Meeting, New York, New York (April 2010)
• Update on Recent Pharma Cases in the U.S., HBM Partners Mountain Retreat (St. Moritz, Switzerland 2009)
• Enterprise Risk Management Through IP Protection, BayBIO Breakfast Series (Palo Alto 2009)
• Cross-Border Business: What You Need To Know, BioContact (Quebec City, Canada 2008)
• Combining Patent and Business Strategies, MBC Entrepreneur’s University (Cambridge 2008)
• Positioning Your Company for Long-Term Relationships: The Value of Effective Patent and Licensing Strategies, Windhover Therapeutic Partnerships (Philadelphia 2008)
• Inconvenient Truths? Recent Patent Law Decisions and Their Impact on Partnering Deals, BioPartnering Europe (London, U.K. 2007)
• Globalization Strategies for Emerging Corporates: Operationilizing Winning Strategies Citigroup Commercial Banking Group, Thought Leadership Roundtable (Mumbai, India 2006)
• Lecturer, Making Effective Business Decisions Involving Intellectual Property and How to Protect and Preserve IP Assets, MCLE (2006)
• Keynote speaker, UBS Global Pharmaceutical Conference (NYC 2000)
• Lecturer, Development and Management of Your Patent Estate, MCLE (1998)
Bar Admissions & Memberships
• Admitted, Massachusetts Bar
• Admitted, United States Court of Appeals for the Federal Circuit
• Registered Patent Attorney, U.S. Patent and Trademark Office
|
|
|
 |
